The University of Virginia Health System is an academic health care center associated with the University of Virginia in Charlottesville. The health system includes a medical center, school of medicine, school of nursing, and health sciences library.

There are 645 beds in University of Virginia Health System.

During the past decade, University of Virginia Health System conducted 284 clinical trials. In the 10-year time frame, 284 clinical trials started and 157 clinical trials were completed, i.e. on average, 55.3% percent of trials that started reached the finish line to date. In the past 5 years, 104 clinical trials started and 100 clinical trials were completed. i.e. 96.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia Health System" #1 sponsor was "University of Virginia" with 80 trials, followed by "Abbott Medical Devices" with 17 trials sponsored, "Bristol-Myers Squibb" with 17 trials sponsored, "Gilead Sciences" with 13 trials sponsored and "Boston Scientific Corporation" with 13 trials sponsored. Other sponsors include 346 different institutions and companies that sponsored additional 227 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia Health System" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 14 trials as a collaborator, "Medical University of South Carolina" with 8 trials as a collaborator, "National Institutes of Health (NIH)" with 7 trials as a collaborator and "Genentech, Inc." with 6 trials as a collaborator. Other collaborators include 258 different institutions and companies that were collaborators in the rest 217 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia Health System" are "Coronary Artery Disease" (18 trials), "Amyotrophic Lateral Sclerosis" (11 trials), "Heart Failure" (11 trials), "Stroke" (9 trials) and "Atrial Fibrillation" (8 trials). Many other conditions were trialed in "University of Virginia Health System" in a lesser frequency.

Most popular intervention types in "University of Virginia Health System" are "Drug" (269 trials), "Device" (128 trials), "Other" (48 trials), "Biological" (35 trials) and "Procedure" (29 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (66 trials), "placebo" (9 trials), "Nivolumab" (7 trials), "Ipilimumab" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia Health System" are 453 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 154 active trials in "University of Virginia Health System". 4 are not yet recruiting, 79 are recruiting, 62 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 234 completed trials in University of Virginia Health System, 1 suspended trials, and 69 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia Health System, 30 "Phase 1" clinical trials were conducted, 122 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 124 trials that are defined as “Not Applicable".

University of Virginia Health System has several departments that took part in Clinical trials: "University of Virginia Cancer Center" - 443 trials, "University of Virginia Cancer Center at UV Health System" - 10 trials, "University of Virginia Adult Neurology" - 9 trials, "UVA CARE Richmond" - 7 trials, "Univ of Virginia Ophthalmology" - 6 trials, "University of Virginia Pain Management Center" - 5 trials, "University of Virginia - Emily Couric Cancer Center" - 4 trials, "University of Virginia Children's Hospital; Developmental" - 2 trials, "University of Virginia - Pediatric Respiratory Medicine" - 2 trials